MetLife Weighted Average Shares Diluted from 2010 to 2024

MET Stock  USD 73.92  0.86  1.18%   
Check MetLife financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MetLife main balance sheet or income statement drivers, such as Depreciation And Amortization of 478 M, Interest Expense of 795.6 M or Selling General Administrative of 5.8 B, as well as many exotic indicators such as Short Term Coverage Ratios of 121, Price Earnings Ratio of 33.34 or Price To Sales Ratio of 0.72. MetLife financial statements analysis is a perfect complement when working with MetLife Valuation or Volatility modules.
  
This module can also supplement MetLife's financial leverage analysis and stock options assessment as well as various MetLife Technical models . Check out the analysis of MetLife Correlation against competitors.
For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.

About MetLife Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include MetLife income statement, its balance sheet, and the statement of cash flows. MetLife investors use historical funamental indicators, such as MetLife's Weighted Average Shares Diluted, to determine how well the company is positioned to perform in the future. Although MetLife investors may use each financial statement separately, they are all related. The changes in MetLife's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MetLife's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MetLife Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MetLife. Please read more on our technical analysis and fundamental analysis pages.
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York. Metlife operates under Insurance - General classification in the United States and is traded on New York Stock Exchange.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MetLife is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if MetLife Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Metlife Stock. Highlighted below are key reports to facilitate an investment decision about Metlife Stock:
Check out the analysis of MetLife Correlation against competitors.
For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.
Note that the MetLife information on this page should be used as a complementary analysis to other MetLife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for MetLife Stock analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is MetLife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetLife. If investors know MetLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetLife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.61)
Dividend Share
2.06
Earnings Share
1.81
Revenue Per Share
88.295
Quarterly Revenue Growth
0.219
The market value of MetLife is measured differently than its book value, which is the value of MetLife that is recorded on the company's balance sheet. Investors also form their own opinion of MetLife's value that differs from its market value or its book value, called intrinsic value, which is MetLife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetLife's market value can be influenced by many factors that don't directly affect MetLife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MetLife's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetLife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetLife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.